NACDS recommended several measures to lower prescription drug prices and improve patient health--including DIR fee relief--to the House Committee on Energy and Commerce Subcommittee on Health.
NACDS Addresses DIR Fees, Other “Access Agenda” Priorities in National Drug-Pricing Policy Discussion NACDS responds to request-for-information from HHS Secretary Azar for “Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs”
NACDS has submitted comments to Health and Human Services Secretary Alex Azar in response to the agency’s request-for-information on drug-pricing public policy issues.
NACDS Advances “Access Agenda” Healthcare Priorities in Statements to Congress NACDS statements to Senate Finance and House Ways and Means Committees outline support for pro-patient, pro-pharmacy healthcare solutions
NACDS outlined support for pro-patient healthcare solutions as Congressional Committees considered the FY2018 Department of Health and Human Services budget.